0001209191-17-041312.txt : 20170622
0001209191-17-041312.hdr.sgml : 20170622
20170622144928
ACCESSION NUMBER: 0001209191-17-041312
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170620
FILED AS OF DATE: 20170622
DATE AS OF CHANGE: 20170622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kite Pharma, Inc.
CENTRAL INDEX KEY: 0001510580
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 2225 COLORADO AVENUE
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
BUSINESS PHONE: (310) 824-9999
MAIL ADDRESS:
STREET 1: 2225 COLORADO AVENUE
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHAMPSI FARAH
CENTRAL INDEX KEY: 0001198321
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36508
FILM NUMBER: 17924879
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-20
0
0001510580
Kite Pharma, Inc.
KITE
0001198321
CHAMPSI FARAH
C/O KITE PHARMA, INC.
2225 COLORADO AVENUE
SANTA MONICA
CA
90404
1
0
0
0
Common Stock
2017-06-20
4
A
0
2410
0.00
A
66074
D
Director Stock Option (Right to Buy)
91.21
2017-06-20
4
A
0
8810
0.00
A
2027-06-19
Common Stock
8810
8810
D
The stock option shall vest in 12 successive equal monthly installments following the date of grant.
/s/ David M. Tanen, Attorney-in-Fact
2017-06-21